tiprankstipranks
The Fly

Sabra Health Care reports Q2 FFO 33c, consensus 34c

Sabra Health Care reports Q2 FFO 33c, consensus 34c

Reports Q2 revenue $161.2M, consensus $158.4M. Commenting on the second quarter’s results, Rick Matros, CEO and Chair, said, “Sabra’s portfolio continues to strengthen as occupancy gains and easing labor pressures drive improved rent coverages. Reimbursement trends also remain encouraging, highlighted by Medicaid rate increases that are trending higher than they have been in many years. We recently held an operators’ conference and while our operators are not yet where they want to be, these encouraging operating trends underpinned a sense of optimism among attendees that was evident and appreciated. Additionally, we are pleased we were able to expeditiously transition the 11 wholly-owned properties that were formerly managed by Enlivant to an existing operator. Our progress this year gives us increased confidence that we are moving past the pandemic, and have greater clarity on future earnings growth as illustrated in the Supplemental Information presentation we issued today.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on SBRA:

Questions or Comments about the article? Write to editor@tipranks.com